Apyx Medical (APYX) Income from Non-Controlling Interests (2013 - 2026)
Apyx Medical's (APYX) quarterly Income from Non-Controlling Interests came in at $171000.0 in Q2 2026, up 327.5% on a YoY basis from $40000.0 in Q2 2025, and up 588.57% quarter-over-quarter from -$35000.0 in Q1 2026.
Powered by 
Analysis
Apyx Medical (APYX) Income from Non-Controlling Interests (2013 - 2026) Analysis & Trends
Apyx Medical (APYX) has reported Income from Non-Controlling Interests for 10 consecutive years, with $171000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Income from Non-Controlling Interests rose 327.5% year-over-year to $171000.0; the trailing twelve-month figure through Jun 2026 stood at $904000.0 (up 6.48% YoY), and the FY2025 full-year result was $786000.0, changed 0.13% from the prior year.
- Income from Non-Controlling Interests improved to $171000.0 in Q2 2026 per APYX's latest filing, from -$35000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $852000.0 in Q4 2024 and bottomed at -$49000.0 in Q1 2023.
- Historically, Income from Non-Controlling Interests has averaged $82111.1 across 5 years, with a median of -$21500.0 in 2024.
- The sharpest annual moves came in 2022 and 2024: Income from Non-Controlling Interests sank 475.0% in 2022, then soared 5111.76% in 2024.
- Over 5 years, Income from Non-Controlling Interests stood at -$16000.0 in 2022, then fell by 6.25% to -$17000.0 in 2023, then jumped by 5111.76% to $852000.0 in 2024, then decreased by 13.26% to $739000.0 in 2025, then sank by 76.86% to $171000.0 in 2026.
- According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered $171000.0, -$35000.0, and $739000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.69 Bn | 175.09 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.23 Bn | 122.02 Bn | 1.96 Bn | 6.60 Mn |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn | 9.00 Mn |
| 4 | Stryker | 103.91 Bn | 100.43 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.54 Bn | 63.00 Bn | 3.85 Bn | -2.00 Mn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn | -500,000.00 |
| 7 | Alcon | 32.96 Bn | 31.51 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.02 Bn | 30.07 Bn | 830.00 Mn | - |
| 9 | Steris | 20.70 Bn | 20.21 Bn | 684.20 Mn | 900,000.00 |
| 10 | Apyx Medical | 131.11 Mn | 103.49 Mn | 8.87 Mn | 171,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 171,000.00 |
| Mar 31, 2026 | -35,000.00 |
| Dec 31, 2025 | 739,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 40,000.00 |
| Mar 31, 2025 | -22,000.00 |
| Dec 31, 2024 | 852,000.00 |
| Sep 30, 2024 | -21,000.00 |
| Jun 30, 2024 | -30,000.00 |
| Mar 31, 2024 | -14,000.00 |
| Dec 31, 2023 | -17,000.00 |
| Sep 30, 2023 | -46,000.00 |
| Jun 30, 2023 | -25,000.00 |
| Mar 31, 2023 | -49,000.00 |
| Dec 31, 2022 | -16,000.00 |
| Sep 30, 2022 | -31,000.00 |
| Jun 30, 2022 | -24,000.00 |
| Mar 31, 2022 | -23,000.00 |
| Dec 31, 2021 | -7,000.00 |
| Sep 30, 2021 | -12,000.00 |